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Background: Evaluation of mitochondrial function offers an alternative to evaluate embryo development for
assessment of oocyte viability, but little information is available on the relationship between mitochondrial and
chromatin status in equine oocytes. We evaluated these parameters in immature equine oocytes either fixed
immediately (IMM) or held overnight in an Earle’s/Hank’s’ M199-based medium in the absence of meiotic inhibitors
(EH treatment), and in mature oocytes. We hypothesized that EH holding may affect mitochondrial function and
that holding temperature may affect the efficiency of meiotic suppression.
Methods: Experiment 1 - Equine oocytes processed immediately or held in EH at uncontrolled temperature (22 to 27°C)
were evaluated for initial chromatin configuration, in vitro maturation (IVM) rates and mitochondrial energy/redox
potential. Experiment 2 - We then investigated the effect of holding temperature (25°C, 30°C, 38°C) on initial chromatin
status of held oocytes, and subsequently repeated mitochondrial energy/redox assessment of oocytes held at 25°C vs.
immediately-evaluated controls.
Results: EH holding at uncontrolled temperature was associated with advancement of germinal vesicle (GV) chromatin
condensation and with meiotic resumption, as well as a lower maturation rate after IVM. Holding did not have a
significant effect on mitochondrial distribution within chromatin configurations. Independent of treatment, oocytes
having condensed chromatin had a significantly higher proportion of perinuclear/pericortical mitochondrial distribution
than did other GV configurations. Holding did not detrimentally affect oocyte energy/redox parameters in viable GV-stage
oocytes. There were no significant differences in chromatin configuration between oocytes held at 25°C and controls,
whereas holding at higher temperature was associated with meiosis resumption and loss of oocytes having the condensed
chromatin GV configuration. Holding at 25°C was not associated with progression of mitochondrial distribution pattern
and there were no significant differences in oocyte energy/redox parameters between these oocytes and controls.
Conclusions: Mitochondrial distribution in equine GV-stage oocytes is correlated with chromatin configuration within the
GV. Progression of chromatin configuration and mitochondrial status during holding are dependent on temperature. EH
holding at 25°C maintains meiotic arrest, viability and mitochondrial potential of equine oocytes. This is the first report on
the effects of EH treatment on oocyte mitochondrial energy/redox potential.
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Use of a modified Earle’s/Hank’s M199 (EH medium, [1])
at room temperature has been shown to effectively main-
tain equine oocytes in meiotic arrest in the absence of
meiotic inhibitors. This oocyte holding technique has been
utilized in studies on both intracytoplasmic sperm injec-
tion (ICSI) and nuclear transfer [2-8], to enable scheduling
of in vitro maturation (IVM) and subsequent manipula-
tions. In two studies, in which direct comparisons were
performed, overnight EH holding was associated with
equine blastocyst developmental rates after IVM and ICSI
equivalent to those for controls: 34% for EH holding vs
25% for immediate culture [1]; and 23% for EH holding vs
17% for culture with roscovitine [3]. This holding tech-
nique is utilized due to the fact that the maturation dur-
ation needed for optimum developmental competence of
equine oocytes is about 30 hours [9]. Holding immature
oocytes before IVM allows scheduling of the onset of mat-
uration [1] and may also allow overnight transport of oo-
cytes from the field to laboratories that can effectively
perform ICSI [6,8].
Despite the growing use of holding equine immature
oocytes for both clinical and research applications, little
information is available on the effect of holding conditions
on oocyte metabolism, or the effect of EH holding on
pregnancy or foaling rates after transfer of blastocysts
from these oocytes. It is possible that holding could posi-
tively affect cytoplasmic maturation, as previously hypoth-
esized for culture in the presence of meiotic inhibitors
[1,10-13], or, alternatively, that it may have negative conse-
quences for oocyte developmental potential. In addition,
the mode by which this method maintains meiotic arrest
is currently unknown; from initial findings in our study,
we hypothesized that holding temperature affects oocyte
meiotic arrest.
The ideal method for determining the effect of holding
conditions on oocyte developmental competence is to in-
vestigate embryo development, pregnancy and foaling after
maturation and fertilization of held oocytes. However, in
the horse, this is not only laborious and expensive, but also
problematic for most laboratories. Repeatable methods for
standard in vitro fertilization (IVF) have still not been de-
veloped in the horse, thus ICSI is currently used to fertilize
equine oocytes in vitro for both research [4,9,14,15] and
clinical applications [6,16]. Only one laboratory has pub-
lished multiple reports presenting effective (>15% per
injected oocyte) in-vitro production of equine ICSI blasto-
cysts [2,9,17-19]; other publications commonly report
blastocyst rates per injected oocyte of <10% [20-25]. For
these reasons, in vitro production of blastocysts followed
by transfer to mares cannot be easily applied as a sensitive
test of equine oocyte cytoplasmic competence in most la-
boratories. Therefore, the identification of alternative ob-
jective oocyte evaluation methods is needed.An alternative method for evaluation of oocyte meta-
bolic function is determination of mitochondrial activity.
Mitochondria serve to power oocyte maturation and are
crucial for supporting events occurring downstream of
sperm penetration [26]. The mitochondria present in
the oocyte at the time of fertilization are responsible for
early embryonic development, as mitochondria replica-
tion does not start in the developing embryo until around
the time of blastocyst formation [27,28]. Mitochondria
affect intracellular redox potential by regulating the NAD
(P)H:NAD(P)+ ratio and by producing reactive oxygen
species (ROS; [29,30]). The redox state of the oocyte, in
turn, affects the kinetics of Ca2+ oscillations at activation
[26] and regulates developmentally-important transcrip-
tion factors [31,32], chromatin remodeling [33], and em-
bryo and fetal development, even influencing postnatal
body weight [34]. Reactive oxygen species play important
roles in intracellular signalling, and colocalization of ROS
and mitochondria has been related to cell health in hepa-
tocytes [35] and in oocytes [36,37]. Thus, the proper
localization and activity of mitochondria within the oocyte
have a direct effect on early embryo development.
Patterns of mitochondrial distribution in mature oo-
cytes vary among species [38]. Mitochondrial distribu-
tion and activity patterns of horse oocytes during
maturation have been previously described [39,40] and our
research group has established a confocal laser scanning
microscopy based multiparametric method for assessment
of oocyte mitochondrial energy/redox status that provides
data consistent with biochemical biomarkers, such as ATP
content and scavenger enzyme activity [41].
In the present study, we used multiparametric epifluores-
cence/confocal microscopy-based analysis to examine the
relationship of mitochondrial energy/redox status to GV
stage (chromatin configuration within the GV) and meiotic
maturation, and to evaluate the effects of EH treatment on
these parameters. The effect of temperature on efficiency of
meiotic suppression during EH treatment was also evaluated.Methods
The study was conducted in Southern Italy (41° North
parallel) during four subsequent breeding seasons (2011 to
2014). The study was performed in accordance with the
ethical standards laid down in the 1964 Declaration of
Helsinki and its subsequent amendments. All the proce-
dures with animals were performed following good veter-
inary practice for animal welfare according to the Italian
law (D.Lgs 116/92).Chemicals
All chemicals were purchased from Sigma-Aldrich (Milano,
Italy) unless otherwise indicated.
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Ovaries from mares of unknown reproductive history were
obtained at two local abattoirs within 3 hours of slaughter,
transported to the laboratory within 30–45 min after collec-
tion in a thermal container set at 30°C and processed for
recovery of cumulus-oocyte complexes (COCs). A follicle-
scraping procedure on follicles 0.5 to 2.5 cm in diameter
was used, as previously described [14]. Only COCs clas-
sified as having an intact cumulus investment and intact
oocyte plasma membrane [14] were selected for culture.
Oocyte holding and study groups
Immature non cultured-oocytes were analyzed either im-
mediately (IMM) or after overnight holding (EH). For
IMM oocytes, the time interval between follicle scraping
and beginning of COC processing for analysis or onset of
IVM culture was less than 2 hours. COCs to be evaluated
after IVM were placed into IVM medium either immedi-
ately (IMM-IVM) or after overnight holding (EH-IVM).
After IVM culture, only oocytes that were at the meta-
phase II (MII) stage, as visualized after staining, were ana-
lyzed for energy/redox status.
COCs assigned to the EH treatment were placed in 5 ml
of a mixture of 40% Earle’s and 40% Hank’s salts-buffered
M199 with 20% fetal calf serum (FCS) in glass vacuum
vials (Venoject – Terumo vt-050sp, Madrid, Spain). Fif-
teen to 50 COCs were put into each vial and the vial was
sealed with a cap and paraffin film. The vial was then laid
down on its side and covered with aluminium foil to block
exposure to room light, and kept at room temperature for
16–18 h. After this holding period, EH COCs were dir-
ectly evaluated or were placed in IVM culture (EH-IVM).
In Exp. 1, COCs were held at largely uncontrolled room
temperature, estimated ranging from 22 to 27°C.
In Exp. 2, the effects of three holding temperatures (25°C,
30°C, and 38°C) on oocyte initial chromatin configuration
were compared with those for immediately-fixed (IMM)
oocytes. EH COCs were held either under air conditioning
set at 25°C (EH-25 group) or in a water bath set at 30°C
(EH-30 group) or in a sealed container in a cell culture
CO2 incubator set at 38.2°C (EH-38 group).
In vitro maturation
In vitro maturation was performed following the procedure
described by Dell’Aquila et al. [14], using TCM-199 with
Earle’s salts, buffered with 4.43 mM HEPES and 33.9 mM
sodium bicarbonate and supplemented with 0.1 g/L L-glu-
tamine, 2 mM sodium pyruvate, 2.92 mM calcium-L-
lactate penthahydrate (Fluka 21175 Serva Feinbiochem
GmbH & Co Heidelberg, Germany No. 29760), 50 μg/mL
gentamicin, 20% (v/v) FCS, gonadotrophins (10 μg/mL
ovine FSH and 20 μg/mL ovine LH) and 1 μg/mL 17β es-
tradiol was used. COCs were cultured for 30 h at 38.2°C
under 5% CO2 in air.Oocyte mitochondria and ROS staining
COCs were denuded of cumulus cells by pipetting in
0.05% trypsin–0.02% EDTA (ECM0920D; Euroclone,
Milan, Italy; immature COCs) or TCM 199 with 20% FCS
containing 80 IU hyaluronidase/mL (mature COCs). De-
generating oocytes (having shrunken, misshapen or frag-
mented cytoplasm) and oocytes not in MII after IVM, as
evaluated after staining, were discarded. Oocytes were
washed and then incubated for 30 min in PBS with 3% bo-
vine serum albumin (BSA) containing 280 nM Mito-
Tracker Orange CMTM Ros (Molecular Probes M-7510,
Oregon, USA) at 38.5°C under 5% CO2. Oocytes were
then washed and incubated for 15 min in PBS with 0.3%
BSA containing 10 μM 2′,7′-dichlorodihydrofluorescein
diacetate (DCDHF DA) to detect intracellular ROS
[37,41]. Oocytes were then washed and fixed overnight at
4°C with 2% paraformaldehyde solution in PBS.
Oocyte nuclear chromatin evaluation
After labeling for mitochondria and ROS determination,
oocytes were stained with 2.5 μg/ml Hoechst 33258 in 3:1
(v/v) glycerol/PBS and kept at 4°C in the dark until obser-
vation. Nuclear chromatin status was observed under a
Nikon Eclipse 600 fluorescent microscope equipped with
a B2A (346 nm excitation/460 nm emission) filter and was
classified according to the criteria of Dell’Aquila et al. [42]
and Hinrichs et al. [9]. Chromatin configurations of germi-
nal vesicle (GV)-stage oocytes were classified as Fluores-
cent Nucleus (FN), having fluorescence throughout the
nucleus; Fibrillar, having chromatin strands throughout
the estimated area of the nucleus; Intermediate, having
chromatin strands or irregular masses of chromatin over
approximately half the estimated nuclear area; or Con-
densed Chromatin (CC), having chromatin condensed
into one small regular or irregular mass. Oocytes having
resumed meiosis were characterized as prometaphase I
(PI), having chromatids in a circular array, or metaphase I
(MI), or MII with first polar body (PB) extruded. Oocytes
in anaphase or telophase were rare and were classified as
MII. After IVM, only oocytes classified as MII were evalu-
ated further. Oocytes with fragmented or non-detected
chromatin were considered to be abnormal and were
discarded.
Assessment of oocyte mitochondrial distribution pattern
Mitochondrial distribution pattern was evaluated at
630× magnification under oil immersion with a Nikon
C1⁄TE2000-U laser scanning confocal microscope. A he-
lium/neon laser ray at 543 nm and the G-2 A filter
(551 nm exposure/576 nm emission) was used to evaluate
MitoTracker Orange CMTM Ros fluorescence. An argon
ion laser ray at 488 nm and B-2 A filter (495 nm expos-
ure/519 nm emission) was used to evaluate DCF fluores-
cence. Scanning to allow three-dimensional distribution
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the top to the bottom of the oocyte, with a step size of
0.45 μm. Criteria for mitochondrial pattern definition
were based on previous studies in equine oocytes
[39-41]: oocytes were separated into two groups as hav-
ing a homogeneous/fine pattern of fluorescence due to
small mitochondrial aggregates (SA) diffused through-
out the cytoplasm, which was considered an indication
of cytoplasmic immaturity, or an heterogeneous peri-
nuclear/pericortical (P/P) distribution pattern of larger
mitochondrial aggregates, with accumulation around
the nucleus and in the periphery, considered to be char-
acteristic of cytoplasmic maturation. Oocytes showing
irregular distribution of large mitochondrial clusters
were classified as abnormal and were not analyzed
further.Quantification of Mitotracker Orange CMTM Ros and DCF
fluorescence intensity
Fluorescence intensity was measured in each oocyte, at
the equatorial plane, with the aid of the EZ-C1 Gold
Version 3.70 software platform for Nikon C1 confocal
microscope, as described previously [37,41]. Fluores-
cence intensity within the programmed scan area was
recorded and plotted against the conventional pixel
unit scale (0–255). Images were taken under fixed con-
ditions with respect to laser energy, signal detection
(gain) and pinhole size.Mitochondria-ROS colocalization analysis
Colocalization analysis of mitochondria and ROS was
performed with the EZ-C1 Gold Version 3.70 software.
Degree of colocalization was reported as a Pearson’s cor-
relation coefficient quantifying the overlap degree be-
tween Mitotracker and DCF fluorescence signals [37,43].Statistical analysis
The proportions of oocytes showing the different chro-
matin configurations and mitochondrial distribution
patterns were compared among groups by Chi-square
test with the Yates correction for continuity. The Fish-
er’s Exact Test was used when a value of <5 was ex-
pected in any cell. For confocal quantification analysis
of mitochondrial activity, intracellular ROS levels and
mitochondria/ROS colocalization, mean values of Mito-
Tracker CMTM Ros and DCF fluorescence intensity
and Pearson’s correlation coefficient were compared by
one-way ANOVA followed by Multiple Comparison
methods (Dunn’s or Holm-Sidak; Sigma Plot software
version 11.0). All comparisons were performed between
treated and control groups and among meiotic stages. A
level of P <0.05 was considered significant.Results
Experiment 1: effects of EH treatment on initial nuclear
chromatin configuration, meiotic competence and
mitochondrial energy/redox potential of equine oocytes
A total of 95 non-cultured oocytes was evaluated for chro-
matin configuration, 45 in the IMM group and 50 in the
EH group, comprising four replicates. EH holding at un-
controlled room temperature significantly affected the
chromatin configuration of non-cultured oocytes (Figure 1).
EH treatment was associated with a significant decrease in
the more juvenile FN (P <0.001) and Fibrillar/Intermediate
chromatin configurations (P <0.05), and with a significant
increase in oocytes exhibiting the more meiotically compe-
tent CC configuration (P <0.01). Notably, 22% of oocytes in
the EH treatment had resumed meiosis (prometaphase I
and metaphase I), vs 0 in the IMM treatment (P <0.01).
Of these 95 oocytes, 11 were not evaluated further due
to degenerated chromatin (n =2) or breakage during pro-
cessing (n =9). The mitochondrial distribution pattern in
the remaining 84 oocytes is presented in Table 1. Thirteen
oocytes (9 in the IMM treatment and 4 in the EH treat-
ment) exhibited abnormal mitochondrial distribution; this
was highest in IMM oocytes having the FN configuration
(44%). There were no significant differences in mitochon-
drial distribution within chromatin configurations between
EH and IMM oocytes (P >0.1), thus, results for oocytes
within the IMM and EH treatments were pooled to deter-
mine the association of chromatin configuration with
mitochondrial distribution. Oocytes in the CC configur-
ation had a significantly higher proportion of the more
mature P/P mitochondrial distribution (16/32, 50%) than
did oocytes having Fibrillar/Intermediate chromatin (2/15,
13%; P <0.05).
Quantitative data of fluorescence intensities for Mito-
tracker Orange CMTM Ros and DCF for 71 non-cultured
oocytes are reported in Table 2; 13 oocytes which had an
abnormal mitochondrial distribution pattern were ex-
cluded from quantitative analysis. There was no effect of
EH treatment on mitochondrial activity, intracellular ROS
levels, or mitochondria/ROS colocalization either when
grouped as total non-cultured oocytes (including oocytes
at the PI/MI stage) or when grouped as total GV-stage oo-
cytes. In oocytes having the CC chromatin configuration,
EH treatment did not affect quantitative energy/redox pa-
rameters. For oocytes having the FN chromatin configur-
ation, EH treatment was associated with significantly
lower mitochondrial activity (P <0.05) and mitochondria/
ROS colocalization (P <0.05) and a tendency for lower
DCF fluorescence (P =0.08).
Overall, 218 in vitro-cultured oocytes (six replicates for
each treatment) were evaluated. Oocyte maturation rate in
the IMM-IVM group was significantly higher than that for
the EH-IVM group (48/85, 56.5% vs 47/133, 35.3%, re-
spectively; P <0.01, Figure 1). Forty-six IMM MII and 34
Figure 1 Effects of holding in EH medium on initial chromatin configuration and meiotic competence of equine oocytes. Legend for meiotic
stages: FN = Homogenous/heterogeneously fluorescent nucleus; F/I = Fibrillar/Intermediate; MI =Metaphase I; MII =Metaphase II, Deg = degenerated
chromatin. Legend for treatments: EH = EH treatment (non-cultured); IMM= Immediate fixing (non cultured); EH-IVM= EH treatment and subsequent
in vitro maturation; IMM-IVM= Immediate in vitro maturation. Chi Square test with the Yates correction: within each group (Non cultured or cultured
for IVM) and for each meiotic stage, EH vs IMM: *P <0.05, **P <0.01 , ***P <0.001; EH-IVM vs IMM-IVM: **P <0.01 , ***P <0.001.
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oxidative status; the remaining 2 IMM MII and 13 EH
MII oocytes were not analysed, as they were damaged dur-
ing handling. The proportion of oocytes showing the het-
erogeneous P/P distribution pattern was significantly
higher (P <0.05) in the EH-IVM than in the IMM-IVM
treatments (Table 1). Fluorescence intensities of Mito-
tracker Orange CMTM Ros and DCF evaluated in MIITable 1 Effects of holding in EH medium on mitochondrial di
after IVM
Treatment Nuclear chromatin
configuration
n. of analyzed oocytes Sma
aggr
EH FN 4 4 (10
F/I 2 2 (10
CC 24 9 (38
PI/MI 11 7 (64
IMM FN 16 6 (38
I 13 11 (8
CC 14 7 (50
PI/MI 0 0 (0)
EH-IVM MII 34 9 (26
IMM-IVM MII 46 25 (5
Legend: Homogenous/heterogeneously fluorescent nucleus (FN); Fibrillar/Interme
Metaphase II (MII).
Chi square test with the Yates correction: between treatments and chromatin confioocytes after IVM are reported in Table 2; 5 oocytes
which had an abnormal mitochondrial distribution pat-
tern were excluded from quantification analysis. Measured
energy status, intracellular ROS levels and mitochondria/
ROS colocalization did not differ between EH-IVM and
IMM-IVM MII oocytes. In comparing energy/redox data
between non-cultured and MII oocytes, MII oocytes, inde-
pendent of treatment, showed significantly higher valuesstribution pattern of equine oocytes examined before or
ll mitochondrial
egates (SA) n. (%)
Perinuclear/pericortical
(P/P) n. (%)
Abnormal n. (%)
0) 0 (0) 0 (0)
0) 0 (0) 0 (0)
) 11 (46) 4 (17)
) 4 (36) 0 (0)
) 3 (19) 7 (44)
4) 2 (15) 0 (0)
) 5 (36) 2 (14)
0 (0) 0 (0)
)a 23 (68)a 2 (6)
5)b 18 (39)b 3 (6)
diate (F/I); Condensed chromatin (CC); Prometaphase I/Metaphase I (PI/MI);
gurations: a vs. b (P <0.05).
Table 2 Effects of holding in EH medium on energy/redox parameters of equine oocytes examined before or after IVM
Treatment Nuclear chromatin
configuration
n. of analyzed oocytes Mitochondrial activity Intracellular
ROS levels
Mitochondria/ROS
colocalization
EH FN 4 387.42 ± 347.10a 661.20 ± 404.12 0.40 ± 0.13a
IMM 9 1248.63 ± 657.93b,* 1330.73 ± 651.51 0.64 ± 0.18b
EH F/I 2 § § §
IMM 13 273.23 ± 142.95 709.72 ± 423.16 0.56 ± 0.23
EH CC 20 545.15 ± 283.98 829.89 ± 336.91 0.63 ± 0.16
IMM 12 509.19 ± 242.27** 882.61 ± 486.82 0.67 ± 0.14
EH PI/MI 11 653.80 ± 191.53 946.64 ± 561.87 0.71 ± 0.11
IMM 0 § § §
EH -IVM POST-IVM MII 32 1112.45 ± 494.10 1434.54 ± 686.00 0.76 ± 0.14
IMM-IVM 43 1372.64 ± 481.34 1982.04 ± 762.74 0.84 ± 0.13
Legend: Homogenous/heterogeneously fluorescent nucleus (FN); Fibrillar/Intermediate (F/I); Condensed chromatin (CC); Prometaphase I/Metaphase I (PI/MI);
Metaphase II (MII). Mitochondrial activity and intracellular ROS levels are presented as MitoTracker and DCF fluorescence intensities expressed in Arbitrary
Densitometric Units (ADU). Mitochondria/ROS colocalization is expressed as Pearson’s correlation coefficient. One-way ANOVA followed by Multiple Comparison
Dunn’s method: a,b P <0.05; *, **P =0.004; § values for categories with fewer than 3 oocytes are not shown.
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cultured oocytes (P <0.05; Table 2). In addition, EH-IVM
MII oocytes showed significantly higher rates of P/P mito-
chondrial pattern than did EH (non-cultured immature)
oocytes (23/34, 67.6% vs 15/41, 45.3%; P <0.05, Table 1).
Experiment 2: effect of holding temperature on initial
chromatin configuration, meiotic competence and
energy/oxidative potential status of equine oocytes
Because the results obtained in Exp. 1, conducted under
variable temperature, indicated that EH treatment failed
to completely suppress meiosis, in contrast to previous re-
ports [1], a second experiment was conducted to deter-
mine whether the holding temperature could affect the
ability of EH treatment to suppress meiosis.
One hundred and nineteen oocytes were evaluated in five
replicates. Holding temperature significantly affected oocyte
nuclear chromatin configuration (Figure 2). When oocytes
were held in EH at 25°C, no differences in chromatin con-
figuration were observed in comparison with the IMM
group; however, holding at higher temperatures (30°C and
38°C) was associated with significant increases in oocytes
resuming meiosis (metaphase I and metaphase II) com-
pared with oocytes in the IMM or 25°C EH held groups.
Subsequently, in order to determine whether holding at
25°C maintained mitochondria/ROS equivalent to that for
IMM oocytes, oocytes held in EH at controlled room
temperature (25°C) were analysed for initial chromatin
configuration, meiotic competence and mitochondrial en-
ergy/redox potential. A total of 72 non-cultured oocytes
was evaluated in two replicates for chromatin configur-
ation, 39 in the IMM group and 33 in the EH group. EH
treatment performed at 25°C did not affect oocyte initial
chromatin configuration (Figure 3), as no differences were
observed in the rates of oocytes of any chromatinconfiguration between EH and IMM groups. Of these 72
oocytes, 7 were not evaluated further due to degener-
ated chromatin (n =4 in the EH group and n =3 in the
IMM group). The mitochondrial distribution pattern in
the remaining 65 oocytes is presented in Table 3. Two
oocytes in the EH treatment exhibited abnormal mito-
chondrial distribution and were excluded from further
analysis. There were no significant differences in mito-
chondrial distribution within chromatin configurations be-
tween EH and IMM oocytes (P >0.1). In the IMM group,
three oocytes were found at the metaphase I stage and
two oocytes were in metaphase II with the second polar
body extruded. All these oocytes exhibited the P/P mito-
chondrial distribution pattern.
Quantitative data of fluorescence intensities for Mito-
tracker Orange CMTM Ros and DCF for 62 non-cultured
oocytes are reported in Table 4. Two EH oocytes which
had an abnormal mitochondrial distribution pattern, and
an IMM CC oocyte with an abnormal shape were ex-
cluded from quantitative analysis. In non-cultured oocytes
held in EH at controlled room temperature, there was no
effect of EH treatment on mitochondrial activity, intracel-
lular ROS levels, or mitochondria/ROS colocalization at
any meiotic stage. Within EH-treated oocytes, no differ-
ences were observed among chromatin configurations for
any energy/redox parameter, however mitochondrial activ-
ity and intracellular ROS levels of oocytes showing FN
chromatin configuration tended to be lower than those for
the other configurations, as observed in Exp. 1. Within
IMM oocytes, significantly higher mitochondrial activity
and ROS levels were found in oocytes resuming meiosis
compared with GV oocytes (F/I vs PI/MI and CC vs
PI/MI; P <0.05). Photomicrographs representative of
oocyte morphology, nuclear chromatin configuration,
mitochondrial and ROS distribution patterns and
Figure 2 Effects of holding temperature on initial chromatin configuration of immature non-cultured equine oocytes. Legend for
meiotic stages as in Figure 1. Chi Square test with the Yates correction, for each meiotic stage: i) IMM vs EH at 25°C: not significant; IMM vs EH at
30°C: **P <0.01; IMM vs EH at 38°C: *P <0.05, **P <0.01; ii) 25°C vs 30°C :#P <0.01; ##P <0.001; 25°C vs 38°C: #P <0.01; iii) EH at 30°C vs EH at 38°C:
not significant.
Figure 3 Effects of holding in EH medium at controlled room
temperature (25°C) on initial chromatin configuration of equine
oocytes. Legend for meiotic stages as in Figures 1 and 2. Chi
Square test with the Yates correction: for each meiotic stage,
EH vs IMM: not significant.
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oocytes are presented in Figure 4. The merged image
shows the simultaneous distribution of overlapping fluor-
escence signals (corresponding to the mitochondria- and
ROS-specific probes) within the oocyte cytoplasmic area;
an increasingly yellow image denotes increasing colocali-
zation. The scatter plot displays how the two variables
(MitoTracker and DCF fluorescent intensities) are corre-
lated. Increasing width of the scatter denotes increasing
variability, increasing length denotes increasing signal inten-
sity. The chromatin categories with the highest prevalence
are shown. Oocytes in lines A and B show homogeneous
mitochondrial distribution and lower fluorescence intensity;
oocytes in lines C-F show heterogeneous P/P mitochondrial
pattern and higher fluorescence intensity, as also expressed
by their longer scatter plot graphs. It should be noted that,
in this figure, mitochondrial distribution are shown on only
one confocal plane, whereas recording of distribution was
performed using all 25 planes obtained.
Discussion
In the first study in this area, Torner et al. [39] presented
the relationship between cumulus morphology and oocyte
mitochondrial pattern in immature horse oocytes. The
present study expands on these results to present the dir-
ect relationship of GV nuclear chromatin configuration to
mitochondrial pattern and activity in equine immature oo-
cytes. Torner et al. [39] reported significantly higher rates
of heterogeneous mitochondrial pattern in oocytes at the
diakinesis than at the diplotene stage. However, these
Table 3 Effects of holding in EH medium at controlled room temperature (25°C) on mitochondrial distribution pattern
of equine oocytes examined before or after IVM
Treatment Nuclear chromatin
configuration
n. of analyzed
oocytes
Small mitochondrial
aggregates (SA) n. (%)
Perinuclear/pericortical
(P/P) n. (%)
Abnormal
n. (%)
EH FN 3 3 (100) 0 (0) 0 (0)
F/I 4 4 (100) 0 (0) 0 (0)
CC 22 12 (55) 8 (36) 2 (9)
PI/MI 0 0 (0) 0 (0) 0 (0)
MII 0 0 (0) 0 (0) 0 (0)
IMM FN 2 2 (100) 0 (0) 0 (0)
F/I 9 4 (44) 5 (56) 0 (0)
CC 20 6 (30) 14 (70) 0 (0)
PI/MI 3 0 (0) 3 (100) 0 (0)
MII 2 0 (0) 2 (100) 0 (0)
Legend: Homogenous/heterogeneously fluorescent nucleus (FN); Fibrillar/Intermediate (F/I); Condensed chromatin (CC); Prometaphase I/Metaphase I (PI/MI);
Metaphase II (MII).
Chi square test with the Yates correction: between treatments and chromatin configurations: NS.
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http://www.rbej.com/content/12/1/99authors had no category for the condensed chromatin con-
figuration; they may have interpreted the CC configurations
in GV oocytes as MI, as they report that 8 of 30 oocytes
fixed at Time 0 were in MI. In our study, less than 5% of
oocytes fixed directly had resumed meiosis. Torner et al.
[39] matured oocytes for different times in vitro and re-
ported increasing values of mitochondrial fluorescence in-
tensities as oocytes progressed through meiosis, however,
mitochondrial activity in immature oocytes showing differ-
ent chromatin configurations within the GV was not re-
ported. In a more recent paper, the same group reported
mitochondrial pattern and activity of equine oocytes recov-
ered by ultrasound-guided follicle aspiration, and fixed im-
mediately [44]. In this study, no significant differences
among chromatin configurations in mitochondrial activityTable 4 Effects of holding in EH medium at controlled room t
of equine oocytes
Treatment Nuclear chromatin
configuration
n. of analyzed
oocytes
EH FN 3
IMM 2
EH F/I 4
IMM 9
EH CC 20
IMM 19
EH PI/MI 0
IMM 3
EH MII 0
IMM 2
Legend: Homogenous/heterogeneously fluorescent nucleus (FN); Fibrillar/Intermedi
Metaphase II (MII). Mitochondrial activity and intracellular ROS levels are presented
Densitometric Units (ADU). Mitochondria/ROS colocalization is expressed as Pearson
Holm-Sidak method: a,b P <0.05; §: values for categories with fewer than 3 oocytesor mitochondrial aggregation pattern was found. Thus, the
present study is the first to demonstrate that in GV-stage
equine oocytes, the CC configuration is associated with
higher rates of the more mature mitochondrial distribution
P/P and with higher mitochondrial activity, compared with
the more juvenile FN and F/I stages.
The results of this study demonstrate that holding of oo-
cytes overnight in a meiosis-inhibitor-free medium before
maturation is not detrimental to oocyte mitochondrial sta-
tus or redox status. Evaluation of the mitochondrial and
oxidative status of immature oocytes was an effective meas-
ure of oocyte viability, as these findings were in agreement
with the hypothesis that the FN configuration represents
chromatin degeneration [9]. Of the IMM oocytes exhi-
biting the FN configuration, 44% showed an abnormalemperature (25°C) on confocal energy/redox parameters
Mitochondrial
activity
Intracellular
ROS levels
Mitochondria/ROS
colocalization
162.89 ± 101.19 172.93 ± 46.40 §
§ § §
437.35 ± 298.64 377.13 ± 181.20 0.40 ± 0.32
623.01 ± 376.96a 421.44 ± 164.87 0.38 ± 0.08
547.82 ± 499.54 278.53 ± 179.28 0.50 ± 0.10
722.93 ± 390.31a 377.92 ± 184.92 0.49 ± 0.19
§ § §
1292 ± 192.36b 643.67 ± 312.69 0.60 ± 0.10
§ § §
§ § §
ate (F/I); Condensed chromatin (CC); Prometaphase I/Metaphase I (PI/MI);
as MitoTracker and DCF fluorescence intensities expressed in Arbitrary
’s correlation coefficient. One-way ANOVA followed by Multiple Comparison
are not shown.
Figure 4 Photomicrographs of equine oocytes fixed after recovery (IMM) or held overnight in EH medium at 25°C (EH), assessed
for nuclear chromatin and energy/redox potential. Bright field, epifluorescence and confocal images indicating morphology (A1-F1),
chromatin configuration (A2-F2), mitochondrial (mt) distribution pattern (A3-F3), intracellular ROS localization (A4-F4), mt/ROS merged
(A5-F5) and the mt/ROS colocalization scatter plot graph (A6-F6; Y axis: mt fluorescence intensity; X axis: ROS fluorescence intensity).
A, EH-treated oocyte showing FN chromatin (A2), homogeneous distribution of small mt aggregates (SA; A3), ubiquitous ROS localization
(A4), poor mt/ROS colocalization (A5), and low fluorescence intensity with wide red/green scatter, supporting lack of colocalization of ROS
and mt signals (A6); B, EH-treated oocyte showing intermediate chromatin (B2), SA mt distribution (B3), but with higher mt intensity and
greater mt/ROS colocalization compared to A (longer and narrower scatter plot); C, EH-treated oocyte showing condensed chromatin (C2;
the nuclear outline in the mt image confirms this as a GV configuration), heterogenous perinuclear and pericortical mt pattern (P/P, C3),
localized ROS distribution in areas with and without mt labeling (C4, C5), and the mt/ROS scatter plot (C6) showing greater fluorescence
intensity than in A and B, with predominance of mt fluorescence (Y axis); D, IMM oocyte showing intermediate chromatin (D2), P/P mt
pattern (D3), ROS localization in areas with and without mt labeling (D4, D5), and less precise mt/ROS colocalization, as shown by the
broader scatter plot (D6); E, IMM oocyte showing condensed chromatin with nuclear outline and heterogeneous mt/ROS distribution,
similar to D; F, IMM-MII oocyte, likely from an atretic follicle, showing MII chromatin at 7:00 (F2; cumulus cell nucleus at 12:00); P/P mt
pattern (F3), ROS localization in areas with and without mt labeling (F4, F5), and a broad scatter plot, suggesting poor mt/ROS colocalization (F6).
The scale bar represents 60 μm.
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chondrial activity in this group was higher than any other
GV configuration, possibly reflecting generation of ROS
during cell death. We noted a higher proportion of FN
configuration in IMM oocytes in Experiment 1 than in Ex-
periment 2; this may have been related to high environ-
mental temperature during the period of this study. The
more mature mitochondrial distribution found in imma-
ture oocytes having the CC configuration supports this
configuration as representing the less juvenile, more
meiotically-competent GV-stage oocyte, as previously re-
ported [9,45]. For CC oocytes, the mitochondrial distri-
bution (Table 1) and activity, intracellular ROS levels, and
mitochondria/ROS colocalization (Table 2) values were
remarkably similar between EH and IMM groups. This
suggests that the CC configuration, which is also found in
human oocytes in follicles of meiotically-competent size
[46], is a stable germinal vesicle stage (persists unchanged
during overnight holding). The maturing oocytes found in
the IMM group were likely from atretic follicles [47], as
oocytes in viable preovulatory equine follicles do not re-
sume meiosis until beyond the maximum follicle size used
for oocyte collection in this study.
Intermediate and CC chromatin configurations in GV-
stage equine oocytes are competent to resume meiosis [9].
Thus, it could be predicted that the MII oocytes in the
IMM group after IVM originated from both Intermediate
and CC GV-stage oocytes, as these are present in about
equal proportions in this group (Figure 1). However, the
MII oocytes resulting in the EH group (Exp. 1) would ap-
pear to originate entirely from CC oocytes, as this was the
only viable GV stage chromatin present after overnight
holding (Figure 1). Therefore, the significant difference seen
in mitochondrial distribution in IVM MII oocytes between
the EH and IMM treatments (Table 1) may be due to the
chromatin status of the GV oocytes at the time they were
placed in maturation culture, with EH oocytes, having
started with the more advanced CC chromatin, showing a
higher prevalence of the P/P distribution, which is associ-
ated with cytoplasmic maturity [39-41].
Assessment of energy and oxidative capacity of EH oo-
cytes in Exp. 1 provides qualitative and quantitative evi-
dence that EH treatment does not lead to a state of
respiratory cell stress, as this treatment was not detrimen-
tal to energy/redox parameters and in fact positively modi-
fied them (higher proportions of the P/P mitochondrial
pattern). Mature (MII) oocytes from both IMM-IVM and
EH-IVM treatments yielded significantly higher values for
all energy/redox parameters when compared with those
for immature oocytes, as reported previously [39].
The resumption of meiosis seen in non-cultured EH oo-
cytes in Exp. 1 contradicted previous findings that EH hold-
ing effectively suppressed meiosis. Choi et al. [1] reported
that equine oocytes in the EH treatment did not matureduring holding (70% germinal vesicle stage after 18 h
holding). Alm et al. [48] reported that the EH treatment
maintained bovine oocytes at the germinal vesicle stage
(79.3%, vs. 87.7% for control oocytes at 0 h; P >0.05). For
these reasons, we performed a second study to examine
the effects of temperature of holding on initial nuclear
chromatin status. We found that holding at a consistent
temperature of 25°C effectively maintained oocytes in the
germinal vesicle stage, in agreement with previous studies
(Figures 3 and 4), and showed for the first time that, at in-
creased temperature, equine oocytes held in EH medium
resume meiosis during holding; the low rate of normal MII
oocytes found after IVM in the EH group in Experiment 1
suggests that increased temperature is detrimental to oo-
cyte viability (Figure 3). Subsequently, we re-examined the
effect of EH holding on oocyte mitochondria/redox values.
Holding in EH when performed at 25°C did not modify oo-
cyte qualitative morphological (Mitochondria distribution
pattern; Table 3) or quantitative (mitochondrial activity,
intracellular ROS levels and mitochondria/ROS colocaliza-
tion; Table 4) energy/redox parameters. These are import-
ant findings given the increasing use of this procedure for
both transport and for scheduling of maturation in equine
oocytes for clinical and research uses.
Conclusions
In summary, evaluation of energy/redox parameters was
effective in defining progression of cytoplasmic maturation
during EH treatment (uncontrolled temperature) and in
detecting incompetent (FN) oocytes. EH holding does not
compromise viability and energy/redox status in equine
oocytes held at room temperature overnight, and progres-
sion of pre-meiotic chromatin configuration and mito-
chondrial status are dependent upon temperature. At
variable room temperature, increased apparent cytoplas-
mic maturation before IVM was reflected in a more ma-
ture mitochondrial distribution in MII oocytes. Consistent
holding at 25°C maintained oocytes in a state indistin-
guishable from IMM oocytes. Our findings support the
use of EH pre-IVM treatment at 25°C to facilitate schedul-
ing and oocyte transport. Further work is needed to deter-
mine if this may offer an option for laboratories working
in farm animals as well as in human IVM. The absence of
meiotic inhibitors in this medium provides a simple and
potentially clinically-suitable pre-maturation method for
application to assisted reproductive technologies.
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